7-93294553-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017667.4(VPS50):āc.1084A>Gā(p.Asn362Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000029 in 1,550,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017667.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS50 | NM_017667.4 | c.1084A>G | p.Asn362Asp | missense_variant | 14/28 | ENST00000305866.10 | NP_060137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS50 | ENST00000305866.10 | c.1084A>G | p.Asn362Asp | missense_variant | 14/28 | 1 | NM_017667.4 | ENSP00000307666.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000191 AC: 4AN: 209554Hom.: 0 AF XY: 0.0000175 AC XY: 2AN XY: 114530
GnomAD4 exome AF: 0.0000300 AC: 42AN: 1398770Hom.: 0 Cov.: 28 AF XY: 0.0000259 AC XY: 18AN XY: 695302
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.1084A>G (p.N362D) alteration is located in exon 14 (coding exon 14) of the VPS50 gene. This alteration results from a A to G substitution at nucleotide position 1084, causing the asparagine (N) at amino acid position 362 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at